lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
791 rows where filing_year = 2010 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 907684 | CYBER SECURITY RESEARCH CONSULTANTS, LLC 3a8799a1-391f-4316-94e1-e80ae8588cc0 | Q1 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2010 | first_quarter | PHA | Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug reimportation from Canada Health Care Reform | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2010-04-01T09:24:37.463000-04:00 | |
| 907715 | MR. THEODORE (TED) JONES a7b616b5-31e1-43d7-86f4-a3c6524fd7f4 | Q1 | MR. THEODORE (TED) JONES | 20926 | PHARMACEUTICAL RESEARCH AND MANUFACTURES OF AMERICA | 2010 | first_quarter | PHA | Trade Association for certain Pharmaceutical Companies | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-01T13:25:01.870000-04:00 | |
| 907930 | HOLLAND & KNIGHT LLP a12f848b-864f-4b89-a2ab-485925ec7f3b | Q1 | HOLLAND & KNIGHT LLP | 18466 | AMERICAN SOCIETY OF HEMATOLOGY | 2010 | first_quarter | PHA | Hematology and Oncology drug research and approval issues. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 20000 | 0 | 0 | 2010-04-05T10:03:04.730000-04:00 | |
| 907936 | HOLLAND & KNIGHT LLP a67ac18b-af17-43f8-84d7-b4f08d8dbf35 | Q1 | HOLLAND & KNIGHT LLP | 18466 | NATIONAL HEMOPHILIA FOUNDATION | 2010 | first_quarter | PHA | Blood and blood product safety; issues related to blood product approvals. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 40000 | 0 | 0 | 2010-04-05T10:05:06.447000-04:00 | |
| 907959 | LONG TERM CARE PHARMACY ALLIANCE 9a4b09b4-d49d-433a-9ff7-8a28c580a9ca | Q1 | LONG TERM CARE PHARMACY ALLIANCE | 400309443 | LONG TERM CARE PHARMACY ALLIANCE | 2010 | first_quarter | PHA | Medicare Part D | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 201000 | 0 | 0 | 2010-04-05T11:26:28.947000-04:00 | |
| 908464 | UNIVERSITY OF IOWA d7d49f12-4f9b-4701-ab53-0962e58441a5 | Q1 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2010 | first_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public. FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2010 Agricultural Appropriations human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),Office of Science & Technology Policy (OSTP),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 110000 | 0 | 0 | 2010-04-07T10:00:52.507000-04:00 | |
| 908566 | PARRY, ROMANI, DECONCINI & SYMMS 08d890b8-9cce-44aa-a28a-cf112cee36c7 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | AMERICAN ASSOCIATION FOR HEALTH FREEDOM | 2010 | first_quarter | PHA | Support of legislation and efforts to guarantee access by health professionals and patients to medications such as estriol and other compounded preparations. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-07T12:07:10.680000-04:00 | |
| 908701 | ACG ADVOCACY 45c26d54-edf7-4d9c-bcc5-382c191730d1 | Q1 | ACG ADVOCACY | 2057 | PFIZER, INC. | 2010 | first_quarter | PHA | Followon Biologics Super MedPAC HRSA - 340B Drug Pricing Program/Pharmacy Affairs | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-07T14:15:14.220000-04:00 | |
| 908768 | PARRY, ROMANI, DECONCINI & SYMMS a29595c0-da63-4947-9ce5-a1a0c8cff16a | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2010 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2010-04-07T15:13:35.247000-04:00 | |
| 908836 | PARRY, ROMANI, DECONCINI & SYMMS 78263cf2-97d9-435c-ba81-cc6bac3d5f5e | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2010 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2010-04-07T16:14:56.623000-04:00 | |
| 908838 | PARRY, ROMANI, DECONCINI & SYMMS 9780379a-e9fd-4e55-b31b-11c795f2d573 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2010 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2010-04-07T16:26:57.970000-04:00 | |
| 908841 | PARRY, ROMANI, DECONCINI & SYMMS b41d0f63-11f9-420c-910c-fb7443c4301e | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2010 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. H.R. 3018, To amend the Controlled Substances Act to address the use of intrathecal pumps. Amends the Controlled Substances Act to revise the definition of "dispense" to include the delivery of a controlled substance through the use of an intrathecal pump by a practitioner acting in the usual course of professional practice. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2010-04-07T16:34:59.313000-04:00 | |
| 908845 | PARRY, ROMANI, DECONCINI & SYMMS 63fbe3d2-22a6-4399-add6-e4c0f027d40e | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | YAVAPAI COLLEGE | 2010 | first_quarter | PHA | Support of funding to assist in the opening of a regional state university in Prescott, AZ as a joint venture between Yavapai Community College and Northern Arizona University. Support of grant proposal to provide funding for the training of allied health professionals. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-07T16:47:02.970000-04:00 | |
| 909305 | DUTKO WORLDWIDE, LLC aefcb527-ab7d-4945-9760-93cd6b338a6a | Q1 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2010 | first_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (S. 510). Affordable Health Care for America Act (H.R.3962), Patient Protection and Affordable Care Act (H.R.3590), America's Affordable Health Choices Act of 2009 (H.R.3200), Affordable Health Choices Act (S.1679), America's Healthy Future Act of 2009 (S.1796). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-08T16:24:42-04:00 | |
| 909503 | MOFFETT GROUP, LLC 9749f972-02b1-4599-a20e-18a012b1ba0f | 1T | MOFFETT GROUP, LLC | 82578 | BOEHRINGER INGELHEIM PHARMECEUTICAL | 2010 | first_quarter | PHA | Phamaceutical issues, especially with respect to the House Energy and Commerce Committee. Our work is specifically related to the Connecticut delegation. | HOUSE OF REPRESENTATIVES,SENATE | 49578 | 0 | 1 | 2010-04-09T11:33:27.447000-04:00 | |
| 909546 | HANCE SCARBOROUGH 63ba0183-1782-4242-9ba9-09ad69cbabb3 | Q1 | HANCE SCARBOROUGH | 17443 | INTRATHECAL CUSTODY ACCOUNT SUPPORTERS (INFORMAL COALITION) | 2010 | first_quarter | PHA | Monitored legislation related to physician control and patient access to intrathecal pump applications for patients with chronic pain. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-09T12:32:22.647000-04:00 | |
| 909574 | HANCE SCARBOROUGH b6d6581c-9b9c-445e-a0b0-b6e2d9e54225 | Q1 | HANCE SCARBOROUGH | 17443 | TEXAS ACADEMY OF COMPOUNDING PHARMACISTS | 2010 | first_quarter | PHA | Federal legislation affecting the practice of pharmacy and FDA regulation of compounded drugs. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-09T13:10:33.023000-04:00 | |
| 909630 | SINGER CONSULTING LLC 36dc3a59-4b9c-457d-9dc4-d48c122878f8 | Q1 | SINGER CONSULTING LLC | 74658 | PFIZER INC. | 2010 | first_quarter | PHA | General corporate | SENATE | 0 | 0 | 2010-04-09T13:58:56.650000-04:00 | ||
| 909817 | GREATER NEW YORK HOSPITAL ASSOCIATION 8cd7cb72-4957-4a06-a1a1-cbd79a24b4c2 | Q1 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2010 | first_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers (various health care reform proposals (including the American Health Care Choices Act (S.1679); H.R.3962; H.R.3590); 340B Program Improvement and Integrity Act of 2009 (H.R. 444/S.1239)) | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE,White House Office | 310000 | 0 | 0 | 2010-04-09T15:52:03.773000-04:00 | |
| 909900 | MEREDITH MCGEHEE 65cecffe-de78-4412-b595-bd07652903d8 | Q1 | MEREDITH MCGEHEE | 79858 | INTERNATIONAL AIDS VACCINE INITIATIVE | 2010 | first_quarter | PHA | Funding for program to develop AIDS vaccines targeted toward the developing world; Working with Global Health Technologies Coalition to educate on research and development programs aimed at the AIDS epidemic; Implementation of PEPFAR; Appropriations for USAID R&D and funding for IAVI; Providing information on "Protocol G" and the "Antibody Project" | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-09T18:26:25.380000-04:00 | |
| 910394 | AMERICAN COLLEGE OF CLINICAL PHARMACY c393ac44-579d-4ce2-a324-8363aa75cd88 | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2010 | first_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 54750 | 0 | 0 | 2010-04-12T14:34:19.143000-04:00 | |
| 910479 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) ae749dd3-7695-4962-ba37-5de3f9f6c643 | Q1 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2010 | first_quarter | PHA | Importation of prescription drugs (S. 525/H.R. 1298), Import Safety (H.R. 759), Rx Pedigree, Counterfeit Drugs (H.R. 1450), Methamphetamine/Pseudoephedrine Regulation (S. 256), Pharmacy Benefit Management (PBM) issues (H.R. 4489) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2010-04-12T15:58:23.313000-04:00 | |
| 910673 | HOLLAND & KNIGHT LLP 9d970ae0-4dda-48d1-9222-014398fded4c | 1T | HOLLAND & KNIGHT LLP | 18466 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2010 | first_quarter | PHA | Issues relating to the biotechnology industry. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 1 | 2010-04-13T10:17:48.157000-04:00 | |
| 911198 | POLICY DIRECTIONS INC. 7bdcc95d-cc56-4395-8e02-0ae5554f9edf | Q1 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2010 | first_quarter | PHA | Antibiotics in animal foods Drug approvals Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. S. 2313/HR3697, all titles, to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-13T14:52:56.507000-04:00 | |
| 911298 | SQUIRE PATTON BOGGS dc17b3ce-0656-4c51-9cbc-77f031e80769 | Q1 | SQUIRE PATTON BOGGS | 30906 | SUNOVION PHARMACEUTICALS INC | 2010 | first_quarter | PHA | Advocacy regarding respiratory drug coverage and H.R. 3590. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2010-04-13T15:16:59.597000-04:00 | |
| 911452 | ANIMAL HEALTH INSTITUTE 09fb0915-3f76-4923-97bc-287daaff322c | Q1 | ANIMAL HEALTH INSTITUTE | 4037 | ANIMAL HEALTH INSTITUTE | 2010 | first_quarter | PHA | Antimicrobial Resistance; HR 1549, S619, Preservation of Antibiotics for Medical Treatment Act; HR2400, Strategies to Address Antimicrobial Resistance Act; S510, Food Safety Modernization Act; HR2749, Food Safety Enhancement Act of 2009; HR3590, Patient Protection and Affordable Care Act; HR 3962, Affordable Health Care for America Act. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-13T16:03:59.087000-04:00 | |
| 911780 | WINBORN SOLUTIONS LLC dc85fa49-f94d-4d01-850f-6e6eb31a1b74 | Q1 | WINBORN SOLUTIONS LLC | 308310 | PERRIGO CO | 2010 | first_quarter | PHA | Dextromethorphan Distribution Act of 2009 Legislation to regulate the sale of psuedoephedrine Food and drug safety, user fee, and country of origin legislation | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2010-04-14T07:33:49.887000-04:00 | |
| 912112 | THE OB-C GROUP, LLC 3eda5ee3-98f5-4db9-b7db-657736456ac0 | Q1 | THE OB-C GROUP, LLC | 29802 | ELI LILLY | 2010 | first_quarter | PHA | HR 1548, Pathway for Biosimilars Act: entire bill. HR 4872, Health Care and Education Reconciliation Act of 2010: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. HR 3590: Patient Protection and Affordable Care Act; matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. No specific bill number: matters relating to pharmaceutical manufacturers in Health Care Reform including Biosimilars. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-14T11:43:54.270000-04:00 | |
| 912201 | JOHNS HOPKINS UNIVERSITY cd46bb2e-5219-426a-b7e4-6798e45da6cd | Q1 | JOHNS HOPKINS UNIVERSITY | 20664 | JOHNS HOPKINS UNIVERSITY | 2010 | first_quarter | PHA | H.R. 444, 340B Program Improvement and Integrity Act of 2009. Extending 340B outpatient pharmaceutical discount to the inpatient setting. | HOUSE OF REPRESENTATIVES,SENATE,White House Office | 110000 | 0 | 0 | 2010-04-14T12:51:22.297000-04:00 | |
| 913471 | BOSE PUBLIC AFFAIRS GROUP d15cef6b-2c29-4ab9-919d-86f82beb3da5 | Q1 | BOSE PUBLIC AFFAIRS GROUP | 297294 | LILLY USA, LLC | 2010 | first_quarter | PHA | Healthcare Reform Bill - 340B Drug Program Extension | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2010-04-15T11:36:23.907000-04:00 | |
| 913490 | AMERICAN ADVERTISING FEDERATION deb32607-7f68-44aa-b9ca-ccbdd666f583 | Q1 | AMERICAN ADVERTISING FEDERATION | 1411 | AMERICAN ADVERTISING FEDERATION | 2010 | first_quarter | PHA | HR 3200, HR 3590, S 1679, S 1796, health care reform legislation as it affects the taxation or content of phamaceutical advertising HR 2175, to prohibit as indecent the broadcasting of any advertisement for a mediation for the treatment of erictile dysfunction Proposals to require a moratorium on the advertising of new prescription medications Proposals to extend Food and Drug Administration authority to advertising for over-the-counter medications | Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-15T11:41:33.533000-04:00 | |
| 913770 | BLUECROSS BLUESHIELD OF TENNESSEE e5106320-1eee-4af3-a483-2118d4a63d48 | Q1 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2010 | first_quarter | PHA | Biologicals S.623 E-Prescribing - Enhanced Health Care Value for All Act Comparative Effectiveness Research Act | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2010-04-15T12:42:25.470000-04:00 | |
| 914108 | APTIV, PLC 032f738d-0275-4046-90f7-2a1ff7801a5f | Q1 | APTIV, PLC | 49054 | APTIV PLC | 2010 | first_quarter | PHA | No activity this quarter | Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),HOUSE OF REPRESENTATIVES,SENATE | 71077 | 0 | 0 | 2010-04-15T14:45:13.220000-04:00 | |
| 914146 | SMITH GARSON FKA SMITH DAWSON & ANDREWS 2743c10f-725a-4660-895d-46648984dbe4 | Q1 | SMITH GARSON FKA SMITH DAWSON & ANDREWS | 35707 | PROSETTA CORPORATION | 2010 | first_quarter | PHA | Government Advertisement of Biopharmaceuticals | SENATE | 0 | 0 | 2010-04-15T14:47:41.277000-04:00 | ||
| 914151 | SMITH GARSON FKA SMITH DAWSON & ANDREWS 9f8c9fa4-ac04-4d06-99b4-97728b8fee47 | Q1 | SMITH GARSON FKA SMITH DAWSON & ANDREWS | 35707 | STRUVE SWINE TECHNOLOGIES | 2010 | first_quarter | PHA | Government Advertisement of Biopharmaceuticals | SENATE | 0 | 0 | 2010-04-15T14:48:43.197000-04:00 | ||
| 914383 | PODESTA GROUP, INC. efbb1541-59de-4b84-b72c-bc1286727c6f | Q1 | PODESTA GROUP, INC. | 31680 | BRISTOL-MYERS SQUIBB | 2010 | first_quarter | PHA | Drug Importation/Drug Safety H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2010-04-15T15:30:01.533000-04:00 | |
| 915768 | BROWN RUDNICK LLP 78d48e61-e4c2-4152-8fa0-7c305a9af427 | Q1 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2010 | first_quarter | PHA | S.525 & S.1232- Pharmaceutical Market Access and Drug Safety Act of 2009 | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2010-04-16T11:09:55.747000-04:00 | |
| 916015 | INDEPENDENCE BLUE CROSS 627f2999-ee18-45d5-b17d-e929b8abcfee | Q1 | INDEPENDENCE BLUE CROSS | 19172 | INDEPENDENCE BLUE CROSS | 2010 | first_quarter | PHA | HR 4489 "To amend Chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program" | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2010-04-16T11:51:08.807000-04:00 | ||
| 916110 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES a141e086-9217-4374-b8d0-4c2a3d873a8d | Q1 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2010 | first_quarter | PHA | H.R.3590, Patient Protection and Affordable Care Act H.R.4872: Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemptionof pharmacies from Medicare accreditation requirements. H.R. 1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exmpetion from Medicare Part B reguations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S. 256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S. 1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R. 2221 Data Accountability and Trust Act, as related to provider privacy requirements. H.R. 4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and dislosure requirements in the FEHBP. S. 3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. | Centers For Medicare and Medicaid Services (CMS),Consumer Product Safety Commission (CPSC),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE,White House Office | 470000 | 0 | 0 | 2010-04-16T12:06:20.230000-04:00 | |
| 916495 | UNIVERSITY OF CONNECTICUT 1439f478-bd11-4a08-9c6a-03acbc9482a7 | Q1 | UNIVERSITY OF CONNECTICUT | 39382 | UNIVERSITY OF CONNECTICUT | 2010 | first_quarter | PHA | Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) | 70000 | 0 | 0 | 2010-04-16T13:50:26.057000-04:00 | |
| 916535 | INDEPENDENCE BLUE CROSS 07c355d0-2bba-48f6-b52f-abda2e2c528f | 1A | INDEPENDENCE BLUE CROSS | 19172 | INDEPENDENCE BLUE CROSS | 2010 | first_quarter | PHA | HR 4489 "To amend Chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program" | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2010-04-16T14:02:22.373000-04:00 | ||
| 917891 | MASSACHUSETTS BIOTECHNOLOGY COUNCIL 8a55e2b7-585a-4db1-bbe9-06fa768c3c75 | Q1 | MASSACHUSETTS BIOTECHNOLOGY COUNCIL | 400271247 | MASSACHUSETTS BIOTECHNOLOGY COUNCIL | 2010 | first_quarter | PHA | Legislation related to biosimilars | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Patent & Trademark Office (PTO),SENATE | 10000 | 0 | 0 | 2010-04-17T15:02:59.723000-04:00 | |
| 918374 | AKIN GUMP STRAUSS HAUER & FELD a9119436-4fe0-4f85-b5bf-733e2f8aac30 | Q1 | AKIN GUMP STRAUSS HAUER & FELD | 682 | PRASCO, INC. | 2010 | first_quarter | PHA | Promoting consumer benefits of authorized generic drugs | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-18T13:25:22.750000-04:00 | |
| 918392 | WINSTON & STRAWN LLP 5ff7d90d-20d9-428b-b593-3023d4f5b439 | Q1 | WINSTON & STRAWN LLP | 41682 | WOCKHARDT USA LLC | 2010 | first_quarter | PHA | Generic drug issues | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-18T13:39:35.320000-04:00 | |
| 918393 | WINSTON & STRAWN LLP e87ca2d7-0633-473a-95f2-1e5a2367a9a3 | Q1 | WINSTON & STRAWN LLP | 41682 | ABRAXIS BIOSCIENCE LLC | 2010 | first_quarter | PHA | Issues related to safety of breast cancer drugs | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2010-04-18T13:42:36.247000-04:00 | ||
| 918467 | WINSTON & STRAWN LLP b7a8b199-1bb0-4507-aad9-f8793d1ad12f | Q1 | WINSTON & STRAWN LLP | 41682 | TEVA PHARMACEUTICALS USA | 2010 | first_quarter | PHA | Biogenerics | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-18T14:54:38.913000-04:00 | |
| 918487 | WINSTON & STRAWN LLP 37ca66db-34f9-4e6d-82c7-543b4c7ac544 | Q1 | WINSTON & STRAWN LLP | 41682 | FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) | 2010 | first_quarter | PHA | Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-18T15:41:02.220000-04:00 | |
| 919367 | POLICY ADVOCATES f3db1220-a850-4688-8306-05967bdbcba0 | Q1 | POLICY ADVOCATES | 72018 | PHOENIX CAPITAL MANAGEMENT LLC | 2010 | first_quarter | PHA | Track and monitor Internet Pharmacy Issues. | HOUSE OF REPRESENTATIVES,SENATE | 16500 | 0 | 0 | 2010-04-19T09:09:16.757000-04:00 | |
| 919908 | EISAI INC. 69de527b-fd7d-4a87-aca1-e2343a927b43 | Q1 | EISAI INC. | 400321512 | EISAI INC. | 2010 | first_quarter | PHA | Biosimilars (a.k.a follow-on biologics) S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education reconciliation Act of 2010 | Education, Dept of,HOUSE OF REPRESENTATIVES,SENATE | 1370000 | 0 | 0 | 2010-04-19T10:36:36.413000-04:00 | |
| 920032 | WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC e87ee4ed-a2c0-4d02-958f-2f89b2bba844 | Q1 | WEXLER | WALKER, A UNIT OF HILL+KNOWLTON STRATEGIES, LLC | 41113 | JARROW FORMULAS, INC. | 2010 | first_quarter | PHA | Federal food safety legislation affecting dietary supplements, and concerning Codex Alimentarius; S. 510 and the Dietary Supplement Health and Education Act | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-19T10:46:41.293000-04:00 | |
| 920316 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 0a50872f-3979-48c6-9ada-d02bfe81f1e4 | Q1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2010 | first_quarter | PHA | Communication with FDA regarding the quality of compounded drugs and improving stakeholder communications; Communications to the Agency for Healthcare Research and Quality regarding nominations to Effective Healthcare Stakeholder Group; Communication with FDA on Risk Evaluation and Mitigation Strategies and Prescription Drug User Fee Act Reauthorization Public Meeting. | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 250000 | 0 | 0 | 2010-04-19T11:07:43.413000-04:00 | |
| 920386 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 8894b1f2-e1aa-4c11-beaa-942fec297cf8 | Q1 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2010 | first_quarter | PHA | H.R. 1204, the "Community Pharmacy Fairness Act of 2009", and S. 2161 Community Pharmacy Fairness Act from the 110th Congress; H.R. 616 and S. 511, the "Access to Durable Medical Equipment Act of 2009"; H.R. 1970 and S. 956, the "Preserve Patient Access to Reputable DMEPOS Providers Act of 2009"; H.R. 6331 (110th Congress), the "Medicare Improvements for Patients and Providers Act of 2008." Sec. 154 related to Medicare DMEPOS competitive acquisition program; and Sec. 172, related to submission of claims by pharmacies located in or contracting with long-term care facilities; Sec. 203, related to pharmacy payment under Medicaid; H.R. 1, "American Recovery and Reinvestment Act - P.L. 111-5 -- provisions related to Health Information Technology and HIPPA requirements; H.R. 5839 of the 110th Congress, the "Safeguarding America's Pharmaceuticals Act of 2008", provision relating to pedigree and track and trace requirements; H.R. 1427, the "Promoting Innovation and Life Savings Medicines Act of 2009"; H.R. 2647 and S. 1390, National Defense Authorization Act for 2010-Provides for the funding for the Department of Defense for fiscal year 2010-including the Tricare pharmacy program; H.R. 3108, the "Medication Therapy Benefits Act of 2009"; S. 1649, the "Weapons of Mass Destruction (WMD) Prevention and Preparednesss Act of 2009, pharmacy provider provisions; S. 1383, the "Dextromethorphan Abuse Reduction Act; H.R.3663: To amend title XVIII of the Social Security Act to delay the date on which the accreditation requirement under the Medicare Program applies to suppliers of durable medical equipment that are pharmacies; H.R. 2891, the "Access to Frontline Health Care Act of 2009"; H.R. 3200, the "America's Affordable Health Choices Act of 2009"; the draft Senate HELP Committee's "Affordable Health Choices Act of 2009"; Senate Finance Committee draft health care reform bill, all provisions related to Medicaid AMP pharmacy reimbursement, Medicare Part B DMEPOS accreditation and surety bond requirements, medication therapy mana… | Centers For Medicare and Medicaid Services (CMS),Congressional Budget Office (CBO),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),SENATE,Small Business Administration (SBA),Treasury, Dept of | 130000 | 0 | 0 | 2010-04-19T11:14:09.377000-04:00 | |
| 920768 | US STRATEGIES bf0df548-3536-4b57-9e72-01071dd419c2 | Q1 | US STRATEGIES | 38825 | NOVOLOGIX (FORMERLY ANCILLARY CARE MANAGEMENT) | 2010 | first_quarter | PHA | Medicare and Medicaid provisions relating to pharmacy and medication management policies | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-19T11:48:33.803000-04:00 | |
| 920806 | BUCHANAN INGERSOLL & ROONEY PC 268b43bb-7e41-40ef-81f0-bc636abf521b | Q1 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GENERIC ANIMAL DRUG ALLIANCE | 2010 | first_quarter | PHA | Legislative issues relating to United States Food & Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-19T11:53:01.503000-04:00 | |
| 920820 | PD FRAZER CONSULTING, INC. 0699cadd-c07c-4152-b237-712d309c0e19 | Q1 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2010 | first_quarter | PHA | Monitor the development of proposed bills about the importation of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-19T11:54:56.773000-04:00 | |
| 921153 | THE DUBERSTEIN GROUP INC. 89cab30a-ed80-4aee-adfb-89eba32c6687 | Q1 | THE DUBERSTEIN GROUP INC. | 12675 | AMERICA'S HEALTH INSURANCE PLANS | 2010 | first_quarter | PHA | Generic biologics, generic prescription drugs - HR 3962, America's Affordable Health Choices Act. Generic biologics - HR 3590, Patient Protection and Affordable Care Act. Healthcare reform, including pharmaceutical issues - HR 4872, Health Care and Education Reconciliation Act of 2010. *Antitrust exemption for pharmacies - HR 1204, To ensure and foster continued patient safety and quality of care by making the antitrust laws apply to negotiations between groups of independent pharmacies and health plans and health insurance issuers (including health plans under parts C and D of the Medicare Program) in the same manner as such laws apply to protected activities under the National Labor Relations Act *Generic biologics - HR 1427, To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; HR 1548, To amend the Public Health Service Act to establish a pathway for the licensure of biosimilar biological products, and for other purposes; S 726, A bill to amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other purposes; HR 3200, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; S 1679, An original bill to make quality, affordable health care available to all Americans, reduce costs, improve health care quality, enhance disease prevention, and strengthen the health care workforce. *Generic drugs - HR 1706, To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes; S 369, A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market. *Prescription drug co-pays and formularies - S 1630, A bill to amend title XVIII of the Social Security Act of improve prescription drug coverage under Medicare part D and to amend t… | HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE | 100000 | 0 | 0 | 2010-04-19T12:26:37.040000-04:00 | |
| 921521 | REINECKE STRATEGIC SOLUTIONS, INC. 61304883-a59c-467a-aa5f-34efdfd20c36 | Q1 | REINECKE STRATEGIC SOLUTIONS, INC. | 298012 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2010 | first_quarter | PHA | FY 2011 Appropriations for the Departments of Labor, Health and Human Services, Education and Related Agencies. Specifically for implementation of medication therapy management services program established in health care reform. H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act. And generally, oversight of pharmacy benefits within the Federal Employees Health Benefits Plan (FEHBP) and other government programs. | SENATE | 10000 | 0 | 0 | 2010-04-19T13:10:15.037000-04:00 | |
| 921557 | MCDERMOTT WILL & SCHULTE LLP 94c169d9-71a8-4edd-aa51-0612d567e5d6 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2010 | first_quarter | PHA | Issues related to Section 340B of the Public Health Service Act. | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2010-04-19T13:17:55.770000-04:00 | ||
| 921585 | KAISER FOUNDATION HEALTH PLAN INC. 9069126e-4191-4083-92ed-003bbac1e0b0 | Q1 | KAISER FOUNDATION HEALTH PLAN INC. | 21027 | KAISER FOUNDATION HEALTH PLAN INC | 2010 | first_quarter | PHA | S 726 Promoting Innovation and Access to Life-Saving Medicine Act To amend the Public Health Service Act to provide for the licensing of biosimilar and biogeneric biological products, and for other products. Sponsor: Schumer (D-NY) | HOUSE OF REPRESENTATIVES,SENATE | 300000 | 0 | 0 | 2010-04-19T13:24:10.410000-04:00 | |
| 921679 | GILBERT'S LLP 13c7cb14-8528-4a8f-bda3-bef167825ce2 | Q1 | GILBERT'S LLP | 67876 | MYLAN LABORATORIES INC | 2010 | first_quarter | PHA | Reform to legislation and regulations affecting pharmaceutical drug approval and marketing | Federal Trade Commission (FTC),SENATE | 105000 | 0 | 0 | 2010-04-19T13:31:54.473000-04:00 | |
| 922044 | MCDERMOTT WILL & SCHULTE LLP d3bb8a06-780c-4251-9a59-90d8a9084230 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2010 | first_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program; seeking to advance H.R. 444, H.R. 3590 | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2010-04-19T14:02:22.693000-04:00 | |
| 922048 | VAN NESS FELDMAN, LLP ed2d33e1-6795-4e5b-b35b-83495829e334 | Q1 | VAN NESS FELDMAN, LLP | 39815 | MCKESSON CORPORATION | 2010 | first_quarter | PHA | H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-19T14:02:24.990000-04:00 | |
| 922362 | OGR 7986a7e2-479b-4a28-b26f-8e963e2e70be | Q1 | OGR | 48827 | SANOFI PASTEUR | 2010 | first_quarter | PHA | vaccine related issues | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2010-04-19T14:29:52.973000-04:00 | |
| 922448 | APOTEX CORP. e7d63d86-ee61-4dc3-a3aa-e29f4d3dfc86 | Q1 | APOTEX CORP. | 310973 | APOTEX CORP. | 2010 | first_quarter | PHA | S. 369, the Preserve Access to Affordable Pharmaceuticals Act S. 1315, the Drug Price Competition Act of 2009 H.R. 3777, the Drug Price Competition Act of 2009 H.R. 3962, Affordable Health Care for America Act, Section 2573, Protecting Consumer Access to Generic Drugs Act H.R. 3962, Affordable Heatlh Care for America Act, Section 2375, Licensure Pathway for Biosimilar Products H.R. 3590, the Patient Protection and Affordable Care Act, Title VII, Subtitle A, Biologics Price Competition and Innovation H.R. 4872, the Health Care and Education Reconciliation Act of 2010 pertaining to patent settlements between brand and generic pharmaceutical manufacturers | Federal Trade Commission (FTC),HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2010-04-19T14:40:28.737000-04:00 | |
| 922581 | THEODOSIOU CONSULTANTS bc6ac23b-925c-4910-a48d-6a1ca1cd469b | Q1 | THEODOSIOU CONSULTANTS | 54621 | THEODOSIOU CONSULTANTS | 2010 | first_quarter | PHA | S. 641 | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2010-04-19T14:53:21.457000-04:00 | ||
| 922686 | AMERICAN HEALTH CARE ASSOCIATION 82043717-c458-48b4-868c-6b08e46bcaaf | Q1 | AMERICAN HEALTH CARE ASSOCIATION | 2491 | AMERICAN HEALTH CARE ASSOCIATION | 2010 | first_quarter | PHA | Updating controlled sustances regulations for long-term care. | Bureau of Citizenship & Immigration Services (BCIS),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),SENATE | 460000 | 0 | 0 | 2010-04-19T14:59:47.753000-04:00 | |
| 922896 | UNIVERSITY OF KANSAS 30e4bad5-5459-4ed7-bf33-b22d2c37d9b7 | Q1 | UNIVERSITY OF KANSAS | 321373 | UNIVERSITY OF KANSAS | 2010 | first_quarter | PHA | Provide briefing on KU School of Pharmacy research agenda and Institute for Advancing Medical Innovation; discuss invitation to federal officials with regulatory authority over pharmaceuticals | Army, Dept of (Other),Education, Dept of,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Joint Chiefs of Staff,Office of Science & Technology Policy (OSTP),President of the U.S.,SENATE | 88550 | 0 | 0 | 2010-04-19T15:17:38.617000-04:00 | |
| 923085 | AARP 27e6c014-95dc-42de-b5de-daa95db2d9e9 | Q1 | AARP | 1694 | AARP | 2010 | first_quarter | PHA | S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcar… | Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office | 3970000 | 0 | 0 | 2010-04-19T15:28:39.583000-04:00 | |
| 923204 | AARP 3275a758-2fa5-452d-becf-3adcccbfdc7d | 1A | AARP | 1694 | AARP | 2010 | first_quarter | PHA | S.525/H.R.1298/S.1232, Pharmaceutical Market Access and Drug Safety Act of 2009 - Discussed legislation which would create a system of safe importation of prescription drugs from abroad. S.726/H.R.1427, Promoting Innovation and Access to Life-Saving Medicine Act - Discussed legislation which would create a pathway for the approval of safe, effective biosimilar and generic biologic drugs. H.R.1706, Protecting Consumer Access to Generic Drugs Act of 2009 - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and for other purposes. S. 369, Preserve Access to Affordable Generics Act - Discussed legislation that would prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market,and for other purposes. S.515/H.R.1260/S.610, Patent Reform Act of 2009 - Discussed legislation that would amend federal patent law to rewrite provisions concerning the conditions for patentability. Specifically, AARP weighed in on the inequitable conduct provisions of the legislation. S. 301, Physician Payments Sunshine Act of 2009 - Discussed legislation that would provide for disclosure of gifts given by pharmaceutical and device manufacturers to physicians. S.1315, Federal Food, Drug and Cosmetic Act Amendment/H.R.3777 Drug Price Competition Act - Lobbied to expand the definition of "first applicant" under such Act to allow a generic drug manufacturer that is currently considered an applicant subsequent to a brand-name manufacturer's 180-day exclusivity period to qualify as a first applicant for purposes of filing an abbreviated application for a new drug. Requires such applicant ot submit a substantially complete application that contains and lawfully maintains a certification for such drug. H.R. 3200 America's Affordable Health Choices Act/S. 1679, Americas Health Choices Act/S.1796, America's Healthy Future Act - Discussed need for affordable quality healthcar… | Administration on Aging,Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Energy, Dept of,Federal Communications Commission (FCC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Housing & Urban Development, Dept of (HUD),Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Office of the Vice President of the United States,Securities & Exchange Commission (SEC),SENATE,Social Security Administration (SSA),Transportation, Dept of (DOT),Treasury, Dept of,White House Office | 3970000 | 0 | 0 | 2010-04-19T15:35:47.317000-04:00 | |
| 923731 | PODESTA GROUP, INC. 1ef724fd-ea01-4fe6-a4bb-3b258574b597 | Q1 | PODESTA GROUP, INC. | 31680 | EISAI INC. | 2010 | first_quarter | PHA | S. 726 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2010-04-19T16:07:11.940000-04:00 | |
| 923762 | THE DUBERSTEIN GROUP INC. 4f846afd-7f85-4534-838f-43497532f14b | Q1 | THE DUBERSTEIN GROUP INC. | 12675 | NORVARTIS CORP | 2010 | first_quarter | PHA | Healthcare reform, including follow-on biologics and other pharmaceutical provisions - HR 3962, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; HR 3590, An act entitled The Patient Protection and Affordable Care Act; HR 4872, Health Care and Education Reconciliation Act of 2010. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2010-04-19T16:09:21.160000-04:00 | |
| 924048 | THE DUBERSTEIN GROUP INC. d97beda2-2d66-4ca5-a511-a2a7bc8bdde2 | Q1 | THE DUBERSTEIN GROUP INC. | 12675 | SANOFI-AVENTIS U.S. INC. | 2010 | first_quarter | PHA | All aspects of healthcare reform, including pharmaceutical provisions - HR 3590, An act entitled The Patient Protection and Affordable Care Act; HR 3962, To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes; HR 4872, Health Care and Education Reconciliation Act of 2010. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2010-04-19T16:30:22.987000-04:00 | |
| 924221 | MEHLMAN CONSULTING, INC. a107e0fa-c219-4097-8676-5db72c0d5a08 | Q1 | MEHLMAN CONSULTING, INC. | 284950 | ABBOTT LABORATORIES | 2010 | first_quarter | PHA | S. 1796, America's Healthy Future Act of 2009; H.R. 3200, America's Affordable Health Choices Act of 2009; H.R. 3962, Affordable Health Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act. H.R. 4872, The Health Care and Education Reconciliation Act of 2010. FDA reforms; Medicare coverage and reimbursement. Follow on Biologics: H.R.1548, Pathway for Biosimilars Act. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2010-04-19T16:43:41.100000-04:00 | |
| 924640 | PODESTA GROUP, INC. 961f0068-8824-4653-88f3-0e66140402da | Q1 | PODESTA GROUP, INC. | 31680 | EMD SERONO INC | 2010 | first_quarter | PHA | H.R. 1427 Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548 Pathway for Biosimilars Act S. 726 Promoting Innovation and Access to Life-Saving Medicine Act Drug Importation H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 1232 Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2892 Department of Homeland Security Appropriations Act, 2010 (Drug Importation Issues) H.R. 3288 Consolidated Appropriations Act, 2010 (Drug Importation Issues) H.R. 2997 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2010 (Drug Importation Issues) | HOUSE OF REPRESENTATIVES,Patent & Trademark Office (PTO),SENATE | 60000 | 0 | 0 | 2010-04-19T17:08:55.883000-04:00 | |
| 924728 | EXPRESS SCRIPTS, INC. 98b831b0-7b9d-4a2b-a0cf-4295ecba2c59 | Q1 | EXPRESS SCRIPTS, INC. | 294416 | EXPRESS SCRIPTS, INC. | 2010 | first_quarter | PHA | Items related to reverse settlement payments between manufacturers--HR 1706, S 369 Policies related to the Federal Employees Health Benefit program's pharmacy benefit program--HR 4489 Design and coverage of pharmacy benefits in health reform legislation as well as PBM disclosure requirements--HR 3590, HR 4872 Policies related to restricting PBMs' ability to manage prescription drug benefits -- HR 4199 | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 380000 | 0 | 0 | 2010-04-19T17:13:29.960000-04:00 | |
| 924777 | BLUE CROSS AND BLUE SHIELD ASSOCIATION cf00b465-a86a-41ea-9368-919f8cfca7a3 | Q1 | BLUE CROSS AND BLUE SHIELD ASSOCIATION | 6358 | BLUE CROSS AND BLUE SHIELD ASSOCIATION | 2010 | first_quarter | PHA | HR 4489 "To amend Chapter 89 of Title 5, United States Code, to ensure program integrity, transparency, and cost savings in the pricing and contracting of prescription drug benefits under the Federal Employees Health Benefit Program" | HOUSE OF REPRESENTATIVES,SENATE | 1800000 | 0 | 0 | 2010-04-19T17:16:50.727000-04:00 | |
| 925057 | CUBIST PHARMACEUTICALS, INC. c19b66f3-5b5f-4050-93cc-2e8db1e8838b | Q1 | CUBIST PHARMACEUTICALS, INC. | 40026226 | CUBIST PHARMACEUTICALS | 2010 | first_quarter | PHA | Medical Research Prescription Drug/Federal Drug Admin/Center for Disease Control/Health and Human Services Issues Antibiotic Resistance Issues H.R. 2400 Strategies to Address Antimicrobial Resistance Act (STAAR) H.R. 2937 MRSA Infection Prevention and Patient Protection Act S. 369 Preserve Access to Affordable Generics Act of 2009 | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 150000 | 0 | 0 | 2010-04-19T17:36:11.717000-04:00 | |
| 925280 | PODESTA GROUP, INC. 9dc526f6-b521-42dc-9a65-8e65120cffee | Q1 | PODESTA GROUP, INC. | 31680 | NOVO NORDISK INC | 2010 | first_quarter | PHA | Drug Importation H.R. 3590 Patient Protection and Affordable Care Act H.R. 4872 Health Care and Education Reconciliation Act of 2010 | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 60000 | 0 | 0 | 2010-04-19T17:51:45.553000-04:00 | |
| 925340 | FOLEY & LARDNER LLP d68ce6f4-f116-4ccf-8bca-80a8de856433 | Q1 | FOLEY & LARDNER LLP | 15042 | ROMARK LABORATORIES, LC | 2010 | first_quarter | PHA | Sale of new anti-viral drug | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2010-04-19T17:56:03.477000-04:00 | |
| 925431 | AMYLIN PHARMACEUTICALS f3ed38ac-ae6a-4b5b-9947-5e0c6aaf89b2 | Q1 | AMYLIN PHARMACEUTICALS | 308536 | AMYLIN PHARMACEUTICALS | 2010 | first_quarter | PHA | Physician Payments Sunshine provision of HR 3590 the Patient Protection and Affordable Care Act and H.R.4872 the Health Care and Education Reconciliation Act of 2010 FDA Risk Evaulation Mitigation Strategies (REMS) Drug Safety Communications Drug importation issues in HR 3590 the Patient Protection and Affordable Care Act and H.R.4872 the Health Care and Education Reconciliation Act of 2010 | HOUSE OF REPRESENTATIVES,SENATE | 320000 | 0 | 0 | 2010-04-19T18:02:38.087000-04:00 | |
| 925698 | WINNING STRATEGIES WASHINGTON 2bd02194-47ef-4438-a63d-ed44b6f55aac | 1T | WINNING STRATEGIES WASHINGTON | 50796 | DIABETES ACCESS TO CARE COALITION (DACC) | 2010 | first_quarter | PHA | Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies-Competitive Bidding Program Issues H.R. 3590 Patient Protection and Affordable Care Act- H.R. 616 Pharmacists Exemption to CMS DME Requirements H.R. 3790 Repeal of Medicare Competitive Acquisition Program for DMEPOS | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 1 | 2010-04-19T18:32:22.820000-04:00 | |
| 925734 | PODESTA GROUP, INC. 40d7e3a3-73e6-4490-83c6-51307b3c3f1f | 1T | PODESTA GROUP, INC. | 31680 | WINNING STRATEGIES WASHINGTON LLC | 2010 | first_quarter | PHA | Medicare, Durable Equipment, Prosthetics, Orthotics and Supplies - Competitive Bidding Program Issues S. 1679 Affordable Health Choices Act H.R. 3200 American Health Choices Act of 2009 Tri Caucus Healthcare Reform Bill S. 1796 Americas Healthy Future Act of 2009 H.R. 616 Pharmacists Exemption to CMS DME Requirements H.R. 3962 Affordable Health Care for America Act H.R. 3590 Patient Protection and Affordable Care Act H.R. 3790 Repeal Of Medicare Competitive Acquisition Program for DMEPOS | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 1 | 2010-04-19T18:36:36.647000-04:00 | |
| 926152 | FLYNN & ASSOCIATES, INC. 3fea84e7-0749-476c-a5f3-bac462b2804d | Q1 | FLYNN & ASSOCIATES, INC. | 15020 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2010 | first_quarter | PHA | Healthcare Reform Legislation Pharmaceutical Industry Employment Issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2010-04-19T20:31:14.367000-04:00 | |
| 926276 | WALMART INC. 24a2f725-c179-412a-9d2c-705299519959 | Q1 | WALMART INC. | 40305 | WALMART INC | 2010 | first_quarter | PHA | H.R. 3108, Medication Therapy Management; H.R. 1970, Pharmacy and Optical Medicare Part B Surety Bond H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, The Helath Care and Education Affordablity Reconciliation Act | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Energy, Dept of,Environmental Protection Agency (EPA),Federal Energy Regulatory Commission (FERC),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Labor, Dept of (DOL),Natl Security Council (NSC),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Trade Representative (USTR),White House Office | 1930000 | 0 | 0 | 2010-04-19T21:15:14.727000-04:00 | |
| 926398 | WINNING STRATEGIES WASHINGTON 82cac48c-9cac-4251-832e-956981fbca86 | Q1 | WINNING STRATEGIES WASHINGTON | 50796 | MEDA PHARMACEUTICALS | 2010 | first_quarter | PHA | FDA Risk Evaluation and Mitigation Strategies | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-19T21:59:02.357000-04:00 | |
| 926401 | AVENUE SOLUTIONS 68fe5370-e013-4e3c-b7bc-feaec5331111 | Q1 | AVENUE SOLUTIONS | 72111 | UNITEDHEALTH GROUP INC | 2010 | first_quarter | PHA | HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2010-04-19T22:00:04.123000-04:00 | |
| 926405 | AVENUE SOLUTIONS dde5bf94-56f9-4e04-aae5-82e8eed764e8 | Q1 | AVENUE SOLUTIONS | 72111 | EXPRESS SCRIPTS INC | 2010 | first_quarter | PHA | HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 1706, Protecting Consumer Access to Generic Drugs Act - generic drugs; HR 3200, America's Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data minimg, pharmaceutical benefit manager excise tax, generic biologics; HR 3590, Patient Protection and Affordable Care Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; HR 3962, Affordable Health Care for America Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics, generic prescription drugs; HR 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act HR 4872, Health Care and Education Reconciliation Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S. 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1630, Affordable Access to Prescription Medications Act - prescription drug co-pays and formularies; S 1679, Affordable Health Choices Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intravenous immune globulin), transparency, data mining, pharmaceutical benefit manager excise tax, generic biologics; S 1796, American's Healthy Future Act - medication therapy management, RDS (retiree prescription drug coverage), IVIG (intrave… | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2010-04-19T22:02:05.403000-04:00 | |
| 926417 | AVENUE SOLUTIONS eb365541-24aa-45e2-b7a6-ad432bc9f271 | Q1 | AVENUE SOLUTIONS | 72111 | AETNA | 2010 | first_quarter | PHA | HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2010-04-19T22:05:10.777000-04:00 | |
| 926422 | AVENUE SOLUTIONS 6e046dce-fcd8-44ef-a8cc-204c390b4ffa | Q1 | AVENUE SOLUTIONS | 72111 | BLUE CROSS BLUE SHIELD ASSOCIATION | 2010 | first_quarter | PHA | HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2010-04-19T22:07:13.997000-04:00 | |
| 926452 | AVENUE SOLUTIONS c4e6a600-cdfe-43f8-a84d-630575a136e2 | Q1 | AVENUE SOLUTIONS | 72111 | HEALTHCARE LEADERSHIP COUNCIL | 2010 | first_quarter | PHA | HR 1204, Community Pharmacy Fairness Act - antitrust exemption for pharmacies; HR 1427, Promoting Innovation and Access to Life Saving Medicine Act - generic biologics; HR 1548, Pathway for Biosimilars Act - generic biologics; HR 3200, America's Affordable Health Choices Act - generic biologics; HR 3590, Patient Protection and Affordable Care Act - generic biologics; HR 3962, Affordable Health Care for America Act - generic biologics; S 369, Preserve Access to Affordable Generics Act - generic drugs; S 726, Promoting Innovation and Access to Life-Saving Medicine Act - generic biologics; S 1679, Affordable Health Choices Act - generic biologics | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2010-04-19T22:18:25.763000-04:00 | |
| 926469 | CAPITOL HILL CONSULTING GROUP 69576bc2-d3b3-4d15-be04-f2e3a89cba89 | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2010 | first_quarter | PHA | Controlled Drug Substances Act (21 USC 13) | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2010-04-19T22:29:33.060000-04:00 | |
| 926798 | VAN SCOYOC ASSOCIATES 26cdc2d0-6974-4d9e-9a02-deada296dc77 | Q1 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF CONNECTICUT | 2010 | first_quarter | PHA | Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA salaries and expenses; and extramural research related issues. | Agriculture, Dept of (USDA),HOUSE OF REPRESENTATIVES,Natl Oceanic & Atmospheric Administration (NOAA),SENATE,Small Business Administration (SBA) | 40000 | 0 | 0 | 2010-04-20T06:12:32.220000-04:00 | |
| 926812 | VAN SCOYOC ASSOCIATES 73ee2d97-0c9f-4c85-8835-285ebcf15d02 | Q1 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF MARYLAND BALTIMORE | 2010 | first_quarter | PHA | No lobbying activity. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2010-04-20T06:13:35.220000-04:00 | |
| 926822 | VAN SCOYOC ASSOCIATES 0cae37f9-c1d5-4eea-bb7a-654c1784d903 | Q1 | VAN SCOYOC ASSOCIATES | 39837 | UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE | 2010 | first_quarter | PHA | Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2011, FDA and USDA funding initiatives; Critical Path Partnership. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2010-04-20T06:14:37.377000-04:00 | |
| 927243 | ASSOCIATION FOR ACCESSIBLE MEDICINES 40b34380-7a6e-4d61-9dd0-8cb0ef733991 | Q1 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 16032 | ASSOCIATION FOR ACCESSIBLE MEDICINES | 2010 | first_quarter | PHA | Generic Biologics, Health Care Reform, Budget Reconciliation, Prescription Drug Safety, Counterfeit Drugs/Import Safety/Pedigree, Authorized Generics, Prescription Drug Importation/Re-Importation, 340B Drug Pricing Program, and generic drugs H.R.1427 and S.726 - Promoting Innovation and Access to Life-Saving Medicines Act, all provisions H.R.1548 - Pathway for Biosimilars Act, all provisions H.R.573, all provisions S.501 - Fair Prescription Drug Competition Act, all provisions S.882 - Drug and Device Accountability Act of 2009, Title I Subtitle A, B, C, and D and Title II H.R. 759 - Food and Drug Administration Globalization Act of 2009, Title II S.525, S.1232, and H.R.1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 H.R.3590 - Patient Protection and Affordable Care Act, Title VII - Improving Access to Innovative Medical Therapies; Section 10609 Generic Drug Labeling H.R.3962 - Affordable Health Care for America Act, Title I Subtitle B Part 3 Section 1149A - Payment for Biosimilar Biological Products; Title V Subtitle C Part 2 - Biosimilars H.R.4872 - Reconciliation Bill, Section 1101, Closing the Medicare Prescription Drug "Donut Hole" | Centers For Medicare and Medicaid Services (CMS),Commerce, Dept of (DOC),Congressional Budget Office (CBO),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE,U.S. Trade Representative (USTR),White House Office | 679260 | 0 | 0 | 2010-04-20T09:07:24.817000-04:00 | |
| 927306 | VENABLE LLP db93eede-38de-4e21-a9bf-0af14eb087b1 | Q1 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2010 | first_quarter | PHA | General issues affecting the pharmaceutical industry | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2010-04-20T09:13:52.303000-04:00 | |
| 927470 | K&L GATES, LLP 0a93b96d-1576-4691-b38c-acbd9927f294 | Q1 | K&L GATES, LLP | 32098 | ABRAXIS BIOSCIENCE, INC. | 2010 | first_quarter | PHA | H.R. 3962 the Affordable Health Care for America Act; H.R. 3590 Senate Leadership's Health Care Overhaul: issues related to the regulation of biologics. | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2010-04-20T09:25:06.067000-04:00 | |
| 927662 | AMERICAN VETERINARY MEDICAL ASSOCIATION 2833592e-188f-4af7-9add-71cee42b9f9d | Q1 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 3630 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 2010 | first_quarter | PHA | S 619/HR 1549, Preservation of Antibiotics for Medical Treatment Act | Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 160000 | 0 | 0 | 2010-04-20T09:39:38.317000-04:00 | |
| 927711 | TARPLIN, DOWNS & YOUNG, LLC b79f3a2b-dd4e-4f09-a348-304291b469e9 | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | HEALTHCARE DISTRIBUTION ALLIANCE (HEALTHCARE DISTRIBUTION MANAGMENT ASSN.) | 2010 | first_quarter | PHA | **see addendum page Importation of prescription drugs (S. 525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Counterfeit Drugs (H.R. 1450) Methamphetamine / Pseudoephedrine Regulation (S. 256) Dextromethorphan Regulation (H.R. 1259) Pharmacy Benefit Management Issues (H.R. 4489) | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2010-04-20T09:42:57.507000-04:00 | |
| 928011 | THE PROCTER AND GAMBLE COMPANY 1502f4ac-6810-41a1-afa2-9707b7f3049b | Q1 | THE PROCTER AND GAMBLE COMPANY | 32225 | THE PROCTER AND GAMBLE COMPANY | 2010 | first_quarter | PHA | H.R. 1359 Secure and Responsible Drug Disposal Act of 2009; H.R. 1191 Safe Drug Disposal Act of 2009; H.R.1259 Dextromethorphan Distribution Act of 2009; S. 1383 Dextromethorphan Abuse Reduction Act of 2009; S. 256 Combat Methamphetamine Enhancement Act of 2009 | Bureau of Citizenship & Immigration Services (BCIS),Commerce, Dept of (DOC),Consumer Product Safety Commission (CPSC),Energy, Dept of,Environmental Protection Agency (EPA),Executive Office of the President (EOP),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Intl Trade Administration (ITA),Justice, Dept of (DOJ),Natl Security Council (NSC),Office of Science & Technology Policy (OSTP),Patent & Trademark Office (PTO),SENATE,State, Dept of (DOS),Treasury, Dept of,U.S. Agency for International Development (USAID),U.S. Customs & Border Protection,U.S. Immigration & Customs Enforcement (ICE),U.S. International Trade Commission (ITC),U.S. Trade Representative (USTR) | 1046127 | 0 | 0 | 2010-04-20T10:04:18.417000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);